DK1891960T3 - Farmeceutisk formulering til behandling af hudsygdom - Google Patents

Farmeceutisk formulering til behandling af hudsygdom

Info

Publication number
DK1891960T3
DK1891960T3 DK06380229.2T DK06380229T DK1891960T3 DK 1891960 T3 DK1891960 T3 DK 1891960T3 DK 06380229 T DK06380229 T DK 06380229T DK 1891960 T3 DK1891960 T3 DK 1891960T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical formulation
skin disease
mainly
clobetasolpropionate
Prior art date
Application number
DK06380229.2T
Other languages
English (en)
Inventor
Barranco Enrique Rossell
Original Assignee
Klever Mode S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klever Mode S L filed Critical Klever Mode S L
Application granted granted Critical
Publication of DK1891960T3 publication Critical patent/DK1891960T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06380229.2T 2006-08-17 2006-08-17 Farmeceutisk formulering til behandling af hudsygdom DK1891960T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06380229A EP1891960B1 (en) 2006-08-17 2006-08-17 Pharmaceutical formula for treating skin disease

Publications (1)

Publication Number Publication Date
DK1891960T3 true DK1891960T3 (da) 2010-02-01

Family

ID=37499927

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06380229.2T DK1891960T3 (da) 2006-08-17 2006-08-17 Farmeceutisk formulering til behandling af hudsygdom

Country Status (15)

Country Link
US (1) US7671044B2 (da)
EP (1) EP1891960B1 (da)
CN (1) CN101522198B (da)
AT (1) ATE444071T1 (da)
AU (1) AU2006347403A1 (da)
BR (1) BRPI0621966A2 (da)
CA (1) CA2661064A1 (da)
DE (1) DE602006009511D1 (da)
DK (1) DK1891960T3 (da)
ES (1) ES2334381T3 (da)
IL (1) IL197035A0 (da)
MX (1) MX2009001631A (da)
PT (1) PT1891960E (da)
RU (1) RU2432952C2 (da)
WO (1) WO2008020091A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2893979B2 (es) * 2020-08-01 2023-02-21 Mc Zosimo S L Procedimiento para la obtención de una formulación para el tratamiento de dermatitis inflamatorias y producto obtenido

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903344B1 (en) * 1997-08-21 2011-01-26 Shiseido Co., Ltd. Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin
WO1999049895A2 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
ES2188426B1 (es) * 2001-12-12 2004-11-16 Rosalia Pidal Fernandez Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
DE602004016958D1 (de) * 2003-02-05 2008-11-20 Galderma Res & Dev Umkehremulsion mit mindestens einem gegenüber wasser empfindlichen wirkstoff und ihre anwendungen in kosmetik und dermatologie
WO2006051287A1 (en) * 2004-11-10 2006-05-18 Arrow International Limited Composition and method for treatment of alopecia areata

Also Published As

Publication number Publication date
IL197035A0 (en) 2009-11-18
CN101522198B (zh) 2011-10-05
MX2009001631A (es) 2009-06-19
AU2006347403A1 (en) 2008-02-21
ATE444071T1 (de) 2009-10-15
DE602006009511D1 (de) 2009-11-12
EP1891960B1 (en) 2009-09-30
ES2334381T3 (es) 2010-03-09
EP1891960A1 (en) 2008-02-27
CA2661064A1 (en) 2008-02-21
US7671044B2 (en) 2010-03-02
WO2008020091A1 (es) 2008-02-21
WO2008020091A8 (es) 2009-04-02
CN101522198A (zh) 2009-09-02
RU2009109356A (ru) 2010-09-27
US20080045487A1 (en) 2008-02-21
PT1891960E (pt) 2010-01-04
RU2432952C2 (ru) 2011-11-10
BRPI0621966A2 (pt) 2011-12-27

Similar Documents

Publication Publication Date Title
EA200701511A1 (ru) Фармацевтические композиции бендамустина, предназначенные для лиофилизации
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CO6761350A2 (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis
CL2011003346A1 (es) Compuestos derivados de 2,3-dihidro-5h-[1,3]tiazolo[3,2-a]pirimidin-5-ona, moduladores de pi3k; composicion farmaceutica; y uso para tratar una enfermedad de base inmunologica, cancer o enfermedad pulmonar en un paciente.
PA8770101A1 (es) Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
AR057946A1 (es) Formulacion de zonisamida de liberacion sostenidda
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
ATE453642T1 (de) Substituierte phenylaminopyrimidine
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
GT200500378A (es) Macrolidos
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
UY29777A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
CR10305A (es) "derivados sustituidos de cromanol y su uso.
UA94036C2 (ru) Фармацевтическая композиция бендамустина, предназначенная для лиофилизации
SV2007002235A (es) Nuevos derivados de pirimidina y su uso ref. bhc041311-sv
CR10092A (es) Nuevos derivados de furopirimidina aciclicos sustituidos y su uso
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
ECSP077843A (es) Tratamiento o prevención del prurito
EA200602002A1 (ru) Применение спинозинов для заживления ран
DE602005023742D1 (de) Formulierung von 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-on mit verzögerter freisetzung
DK1891960T3 (da) Farmeceutisk formulering til behandling af hudsygdom
ITMI20021866A1 (it) Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
AR056557A1 (es) Monohidrato de 4-(4-bromo-2-fluoroanilino)-6-metoxi-7-(1-metilpiperidin-4-ilmetoxi)quinazolina (zd6474)
WO2006087147A3 (en) Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia